(R)-Hexahydropyrazino[2,1-c][1,4]oxazin-4(3H)-one hydrochloride, 95.0%, 5g

1-[(benzyloxy)carbonyl]-3-hydroxyazetidine-3-carboxylic acid, 95.0%, 250mg

1,4-Diiodobutane, 95.0%, 100g

4-(Bromomethyl)cyclohexanecarboxylic acid, 100mg

1,2-Dimethyl-1H-benzo[d]imidazole-5-carbaldehyde, 95.0%, 1g

2-{2-Methyl-5-[4-(methylsulfanyl)phenyl]-1H-pyrrol-1-yl}ethan-1-ol, 98%, 5g

Double neck round bottom flasks side neck parallel, 2000 ml, 29/32, 1 Piece

(3aS,4R,6S,7R,7aR)-4-(Hydroxymethyl)-6-(4-methoxyphenoxy)-2,2-dimethyltetrahydro-4H-[1,3]dioxolo[4,5-c]pyran-7-ol, 97%, 1g

2-bromo-N-(3,4-dichlorophenyl)acetamide, 1g

2-BROMO-3,4-DIFLUOROPHENYLACETONITRILE, 95.0%, 250mg

tert-Butyl (3R,5S)-6-hydroxy-3,5-O-isopropylidene-3,5-dihydroxyhexanoate, 95.0%, 25g

1-(4-Bromophenyl)-7,8-dimethoxy-4-methyl-4,5-dihydro-3H-benzo[d][1,2]diazepine, 97%, 5g

6-(4-Chlorophenyl)nicotinaldehyde, 95.0%, 250mg